Skip to main content

Table 2 C282Y and H63D HFE and A736V TMPRSS6 genotypes of 183 CHD patients and 188 healthy controls from the Val Borbera study (p = ns)

From: The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis

 

All patients

Controls

HFE C282Y and H63D*

N = 199

N = 188

wt/wt

139 (69.0)

112 (59.6)

H63D/wt

46 (23.0)

54 (28.7)

H63D/H63D

5 (2.5)

8 (4.3)

C282Y/wt

8 (4.0)

12 (6.4)

C282Y/H63D

3 (1.5)

2 (1.0)

TMPRSS6 A736V

N = 183

N = 188

A/A

61 (33.3)

60 (31.9)

A/V

75 (41.0)

93 (49.5)

V/V

47 (25.7)

35 (18.6)